Swiss pharmaceutical company Roche is buying U.S. diagnostic firm GeneWEAVE for up to $425 million. Through the acquisition, Roche is said to have strengthened its presence in the antimicrobial research industry.
Swiss pharmaceutical company Roche is buying U.S. diagnostic firm GeneWEAVE for up to $425 million. Through the acquisition, Roche is said to have strengthened its presence in the antimicrobial research industry.
Share this Article
Recommended